fluxd.news

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) · fluxd.news

LIVE

Fintech

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Globenewswire·April 3, 2026 at 12:00 PM

CARMEL, Ind., April 03, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the...

Original Source

Globenewswire — www.globenewswire.com

Related in Fintech

Treasury Shares Cybersecurity Intel with Crypto Firms
PYMNTS
New Stablecoin Rules Affect Banks and FinTechs
PYMNTS
HOA fees strain household budgets
PYMNTS
Anthropic launches AI agents product
PYMNTS